Randomized study of repaglinide alone and in combination with metformin in Chinese subjects with type 2 diabetes naive to oral antidiabetes therapy

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Expert Opinion on Pharmacotherapy

• Publication date

  2011-11-18

• Fields of study

  Medicine

• Identifiers
  DOI 10.1517/14656566.2011.602341PMID 21780853
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Standards of Medical Care in Diabetes—2011

  2011cited by this paper
• Prevalence of diabetes among men and women in China.

  2010cited by this paper
• Prevalence of diabetes among men and women in China.

  2010influential reference
• Diabetes in Asia: epidemiology, risk factors, and pathophysiology.

  2009influential reference
• Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy

  2009cited by this paper
• Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control.

  2009influential reference
• Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A Consensus Statement of the American Diabetes Association and the European Association for the Study of Diabetes

  2009cited by this paper
• CENTER FOR DRUG EVALUATION AND RESEARCH

  2009cited by this paper
• Importance of Postprandial Glucose Levels as a Target for Glycemic Control in Type 2 Diabetes

  2009cited by this paper
• Oral combination therapy: repaglinide plus metformin for treatment of type 2 diabetes

  2008cited by this paper
• 中国2型糖尿病防治指南(2007年版)

  2008cited by this paper
• Role of metformin in the initiation of pharmacotherapy for type 2 diabetes: an Asian-Pacific perspective.

  2007cited by this paper
• Targeting hyperglycaemia with either metformin or repaglinide in non‐obese patients with type 2 diabetes: results from a randomized crossover trial

  2007cited by this paper
• Safety of Type 2 Diabetes Treatment With Repaglinide Compared With Glibenclamide in Elderly People

  2006cited by this paper
• Earlier intervention in type 2 diabetes: The case for achieving early and sustained glycaemic control

  2005cited by this paper
• Major causes of death among men and women in China.

  2005influential reference
• Regression of Carotid Atherosclerosis by Control of Postprandial Hyperglycemia in Type 2 Diabetes Mellitus

  2004cited by this paper
• UK prospective diabetes study (UKPDS)

  2004cited by this paper
• The burden of treatment failure in type 2 diabetes.

  2004cited by this paper
• Comparison between repaglinide and glimepiride in patients with type 2 diabetes mellitus: a one-year, randomized, double-blind assessment of metabolic parameters and cardiovascular risk factors.

  2003cited by this paper
• Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria.

  2001cited by this paper
• Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

  2000cited by this paper
• Effect of repaglinide addition to metformin monotherapy on glycemic control in patients with type 2 diabetes.

  1999cited by this paper
• Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)

  1998cited by this paper
• Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Prevalence of Diabetes and Its Risk Factors in China, 1994

  1997cited by this paper
• Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up

  1996cited by this paper
• UK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance.

  1991cited by this paper

• Efficacy and Safety of DPP-4 Inhibitors and Metformin Combinations in Type 2 Diabetes: A Systematic Literature Review and Network Meta-Analysis

  2024cites this paper
• Therapeutic medications against diabetes: What we have and what we expect.

  2019cites this paper
• Standards of medical care for type 2 diabetes in China 2019

  2019cites this paper
• The Effect of Repaglinide on Polycystic Ovary Induced by Testosterone Enanthate in NMRI Mice

  2017cites this paper
• Comparative research on insulin detemir combined with repaglinide and insulin aspart 30 in treating aged type 2 diabetes mellitus

  2016cites this paper
• Standards of care for type 2 diabetes in China

  2016cites this paper
• Advantages and Pitfalls of Antihyperglycemic Combination Pills as First-Line Therapy in the Management of Type 2 Diabetes

  2016influential citation
• Therapeutic Class Overview Attention Deficit/Hyperactivity Disorder (ADHD) Agents and Stimulants

  2014cites this paper
• Early therapy for type 2 diabetes in China.

  2014cites this paper
• Sulfonylureas and meglitinides: historical and contemporary issues.

  2013cites this paper
• The role of nateglinide and repaglinide, derivatives of meglitinide, in the treatment of type 2 diabetes mellitus

  2013cites this paper
• Repaglinide

  2012cites this paper